Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 195
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
MDMA-Assisted Psychotherapy for PTSD: Interviewing Dr. Rachel Yehuda
Nova Mentis and KGK Science Form Tactical Partnership
Numinus Wellness Inc. Graduates to the OTCQX Best Market
atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental...
Introducing Vital: Immersive, Inclusive, and Personal Psychedelic Training for Professionals
Psychedelic Perceptions in 2021: Popular Culture & Controversy
Filament Health Subsidiary Psilo Scientific Announces Inclusion in Health Canada List...
Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research...
PharmaDrug Announces Initiation of Manufacturing of Cepharanthine (PD-001) For Clinical Programs...
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022
Load more